Celgene

CELG

Delayed Nasdaq Other stock markets 04:00:00 2019-11-20 pm EST			5-day change	1st Jan Change
108.2 ^USD	+0.10%		-1.97%	+68.89%

2023	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	CI
2021	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	CI

Celgene Corporation(NasdaqGM:CELG) dropped from S&P TMI Index

November 21, 2019 at 12:00 am EST

Latest news about Celgene

Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	23-06-14	CI
Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	21-09-07	CI
Celgene Corporation Will Grant Sun Pharmaceutical Industries Limited A License to Celgene's Patents Required to Manufacture and Sell Certain Limited Quantity	21-06-21	CI
Celgene Corporation Issues Notice of Redemption of Notes	21-02-22	CI
Bristol-Myers Squibb Company and Celgene Corporation Announce Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion	21-02-04	CI
Ikena Oncology, Inc. announced that it has received $120 million in funding from a group of investors	21-01-04	CI
Amgen : Signs Licensing Agreement With Medicines Development for Global Health	20-12-22	MT
Bristol Myers Squibb : Q3 Results Beat Estimates; Raises 2020 EPS Outlook	20-11-05	MT
Silverback Therapeutics, Inc. announced that it has received $84.999996 million in funding from a group of investors	20-09-22	CI
Silverback Therapeutics, Inc. announced that it expects to receive $84.999996 million in funding from a group of investors	20-09-21	CI
Agios Pharmaceuticals, Inc. Provides Update on 2016 Collaboration Agreement with Celgene	20-03-25	CI
Silverback Therapeutics, Inc. announced that it has received $68.400013 million in funding from a group of investors	20-03-10	CI
Pulmonary Fibrosis Foundation Launches Industry Consortium to Identify Biomarkers in Pulmonary Fibrosis	20-03-04	CI
DISH Network : Democratic lawmaker presses antitrust enforcers on company ties, settlements	20-01-07	RE
Galecto, Inc. acquired PharmAkea, Inc. from Bay City Capital LLC and Celgene Corporation for $17.4 million	20-01-06	CI
GNS Healthcare, Inc. announced that it has received $28 million in funding from Cigna Ventures, Amgen Ventures, Celgene Corporation, Echo Health Ventures, Alexandria Venture Investments, LLC, Merck Global Health Innovation Fund, LLC, and another investor	20-01-06	CI
More drugmakers hike U.S. prices as new year begins	20-01-01	RE
Dealmakers eye cross-border M&A recovery as mega mergers roll on	19-12-31	RE
Oncorus, Inc. announced that it has received $89.6 million in funding from a group of investors	19-12-19	CI
Amgen raises 2019 profit, sales view after buying Celgene psoriasis drug	19-11-21	RE
Celgene Corporation(NasdaqGM:CELG) dropped from S&P 500 Growth	19-11-21	CI
Celgene Corporation(NasdaqGM:CELG) dropped from S&P TMI Index	19-11-21	CI
Celgene Corporation(NasdaqGM:CELG) dropped from INDUSTRIALS	19-11-21	CI
Celgene Corporation(NasdaqGM:CELG) dropped from S&P 500 Value	19-11-21	CI
Celgene Corporation(NasdaqGM:CELG) dropped from S&P Global 1200	19-11-21	CI

Celgene Corporation specializes in the design, development, and sale of products for treating cancer and immune system disorders. Net sales break down by product family as follows: - therapeutic products (99.9%); - other (0.1%): cellular therapy products and biological materials for implants, for tissue and organ treatments, and for therapeutic product development. Net sales are distributed geographically as follows: the United States (65.6%), Europe (24.7%) and other (9.7%).

Sector

More about the company

Celgene

Equities

CELG

Celgene Corporation(NasdaqGM:CELG) dropped from S&P TMI Index

Latest news about Celgene

Chart Celgene

Company Profile